CELL INTELLIGENCE · 肿瘤细胞治疗研究

Arlocabtagene autoleucel：一种用于重度预治疗复发/难治性多发性骨髓瘤的靶向 GPRC5D CAR-T 细胞疗法

Arlocabtagene autoleucel: a GPRC5D-targeted CAR T-cell therapy for heavily pretreated relapsed/refractory multiple myeloma.

整合免疫疗法治疗多发性骨髓瘤

Integrating Immune Therapies for the Treatment of Multiple Myeloma.

多发性骨髓瘤当前的新型靶向治疗策略

Current Novel Targeted Therapeutic Strategies in Multiple Myeloma.

无限可能以及如何利用它们？最佳治疗顺序是什么？

Endless possibilities and how to exploit them? What is the optimal treatment sequence?

多发性骨髓瘤治疗前线的革命：寻找治愈方法的经验与挑战

Revolutions at the frontline of multiple myeloma treatment: lessons and challenges to finding a cure.

多发性骨髓瘤的演变格局：从风险分层到 T 细胞导向的先进疗法

The Evolving Landscape in Multiple Myeloma: From Risk Stratification to T Cell-Directed Advanced Therapies.

动态可靶向细胞外囊泡表面蛋白监测 CAR-T 治疗的缓解深度

Dynamic Targetable Extracellular Vesicle Surface Proteins Monitor Depth of Response to CAR T Therapy.

超越 BCMA：多发性骨髓瘤 CAR-T 细胞治疗的下一波浪潮

Beyond BCMA: the next wave of CAR T cell therapy in multiple myeloma.

靶向多发性骨髓瘤中的 GPRC5D

Targeting GPRC5D in multiple myeloma.

我们提出了关于各类基于 GPRC5D 的疗法在 MM 治疗格局中潜在应用的见解，无论是单独使用还是与已有疗法联合。